Clin Exp Vaccine Res.  2012 Jul;1(1):18-34. 10.7774/cevr.2012.1.1.18.

A review of vaccine development and research for industry animals in Korea

• Lee NH
• Lee JA
• Park SY
• Song CS
• Choi IS
• Lee JB

• KMID: 2278786
• DOI: http://doi.org/10.7774/cevr.2012.1.1.18

Abstract

Vaccination has proven to be the most cost-effective strategy for controlling a wide variety of infectious diseases in humans and animals. For the last decade, veterinary vaccines have been substantially developed and demonstrated their effectiveness against many diseases. Nevertheless, new vaccines are greatly demanded to effectively control newly- and re-emerging pathogens in livestock. However, development of veterinary vaccines is a challenging task, in part, due to a variety of pathogens, hosts, and the uniqueness of host-susceptibility to each pathogen. Therefore, novel concepts of vaccines should be explored to overcome the limitation of conventional vaccines. There have been greatly advanced in the completion of genomic sequencing of pathogens, the application of comparative genomic and transcriptome analysis. This would facilitate to open opportunities up to investigate a new generation of vaccines; recombinant subunit vaccine, virus-like particle, DNA vaccine, and vector-vehicle vaccine. Currently, such types of vaccines are being actively explored against various livestock diseases, affording numerous advantages over conventional vaccines, including ease of production, immunogenicity, safety, and multivalency in a single shot. In this articles, the authors present the current status of the development of veterinary vaccines at large as well as research activities conducted in Korea.

Keyword

Live vaccine; Killed vaccine; Industry animal; Vector vaccine; Development

MeSH Terms

Animals
Communicable Diseases
DNA
Gene Expression Profiling
Humans
Korea
Livestock
Vaccination
Vaccines
DNA
Vaccines

Reference

1. The vaccination history of small-pox cases. Br Med J. 1902. 2:67–68.

2. Clark HF, Kritchevsky D. Growth and attenuation of rabies virus in cell cultures of reptilian origin. Proc Soc Exp Biol Med. 1972. 139:1317–1325.

3. Weller TH, Enders JF, Robbins FC, Stoddard MB. Studies on the cultivation of poliomyelitis viruses in tissue culture. I. The propagation of poliomyelitis viruses in suspended cell cultures of various human tissues. J Immunol. 1952. 69:645–671.

4. Syverton JT, Scherer WF. Studies on the propagation in vitro of poliomyelitis viruses. I. Viral multiplications in tissue cultures employing monkey and human testicular cells. J Exp Med. 1952. 96:355–367.

5. Meeusen EN, Walker J, Peters A, Pastoret PP, Jungersen G. Current status of veterinary vaccines. Clin Microbiol Rev. 2007. 20:489–510.

6. Casewell M, Friis C, Marco E, McMullin P, Phillips I. The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. J Antimicrob Chemother. 2003. 52:159–161.

7. Flynn D. South Korea bans antibiotics in animal feed. 2011. Seattle: Food Safety News.

8. Kuehn BM. FDA aims to curb farm use of antibiotics. JAMA. 2012. 307:2244–2245.

9. Thole JE, van Dalen PJ, Havenith CE, et al. Live bacterial delivery systems for development of mucosal vaccines. Curr Opin Mol Ther. 2000. 2:94–99.

10. Lütticken D, Segers RP, Visser N. Veterinary vaccines for public health and prevention of viral and bacterial zoonotic diseases. Rev Sci Tech. 2007. 26:165–177.

11. Muskett JC, Reed NE, Thornton DH. Increased virulence of an infectious bursal disease live virus vaccine after passage in chicks. Vaccine. 1985. 3:309–312.

12. Rahman MM, Uyangaa E, Han YW, et al. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-alpha alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2. Vet Microbiol. 2011. 154:140–151.

13. Song DS, Yang JS, Oh JS, Han JH, Park BK. Differentiation of a Vero cell adapted porcine epidemic diarrhea virus from Korean field strains by restriction fragment length polymorphism analysis of ORF 3. Vaccine. 2003. 21:1833–1842.

14. Hong SH, Byun YH, Nguyen CT, et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine. 2012. 30:466–474.

15. Kim Y, Kim J, Kang K, Lyoo YS. Characterization of the recombinant proteins of porcine circovirus type2 field isolate expressed in the baculovirus system. J Vet Sci. 2002. 3:19–23.

16. Lee YJ, Sung HW, Choi JG, et al. Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins. J Vet Sci. 2008. 9:301–308.

17. Bae JY, Moon SH, Choi JA, et al. Recombinant DNA and protein vaccines for foot-and-mouth disease induce humoral and cellular immune responses in mice. Immune Netw. 2009. 9:265–273.

18. Yang DK, Kweon CH, Kim BH, et al. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice. J Vet Sci. 2005. 6:125–133.

19. Gerdts V, Mutwiri GK, Tikoo SK, Babiuk LA. Mucosal delivery of vaccines in domestic animals. Vet Res. 2006. 37:487–510.

20. Han YW, Aleyas AG, George JA, et al. Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus. Exp Mol Med. 2008. 40:583–595.

21. van Oirschot JT. Diva vaccines that reduce virus transmission. J Biotechnol. 1999. 73:195–205.

22. van Oirschot JT, Rziha HJ, Moonen PJ, Pol JM, van Zaane D. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J Gen Virol. 1986. 67(Pt 6):1179–1182.

23. van Engelenburg FA, Kaashoek MJ, Rijsewijk FA, et al. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J Gen Virol. 1994. 75(Pt 9):2311–2318.

24. Kaashoek MJ, Moerman A, Madic J, et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine. 1994. 12:439–444.

25. Penrith ML, Vosloo W, Mather C. Classical swine fever (hog cholera): review of aspects relevant to control. Transbound Emerg Dis. 2011. 58:187–196.

26. Moormann RJ, Bouma A, Kramps JA, Terpstra C, De Smit HJ. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol. 2000. 73:209–219.

27. van Zijl M, Wensvoort G, de Kluyver E, et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol. 1991. 65:2761–2765.

28. Lee DH, Park JK, Lee YN, et al. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine. 2011. 29:4003–4007.

29. Yeh JY, Chung KM, Song J. Differentiation of west nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1. Vector Borne Zoonotic Dis. 2012. 12:380–387.

30. Park JK, Lee DH, Youn HN, et al. Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy. Influenza Other Respi Viruses. 2012. 06. 21. [Epub]. http://dx.doi.org/10.1111/j.1750-2659.2012.00396.x.

31. Whetstone CA, Miller JM, Seal BS, Bello LJ, Lawrence WC. Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch Virol. 1992. 122:207–214.

32. Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A. 2006. 103:8203–8208.

33. Ansari IH, Kwon B, Osorio FA, Pattnaik AK. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol. 2006. 80:3994–4004.

34. Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 1993. 67:5664–5667.

35. Serezani CH, Franco AR, Wajc M, et al. Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine. Vaccine. 2002. 20:3755–3763.

36. Mielcarek N, Alonso S, Locht C. Nasal vaccination using live bacterial vectors. Adv Drug Deliv Rev. 2001. 51:55–69.

37. Young KR, McBurney SP, Karkhanis LU, Ross TM. Virus-like particles: designing an effective AIDS vaccine. Methods. 2006. 40:98–117.

38. Wong HT, Cheng SC, Sin FW, Chan EW, Sheng ZT, Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine. 2002. 20:2641–2647.

39. Kim SJ, Sung HW, Han JH, Jackwood D, Kwon HM. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines. Vet Microbiol. 2004. 101:39–51.

40. Hwang DY, Lee JB, Kim TJ, et al. Induction of immune responses to glycoprotein gD of Aujeszky's disease virus with DNA immunization. J Vet Med Sci. 2001. 63:659–662.

41. Dutta NK, Mazumdar K, Lee BH, et al. Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine. Immunol Lett. 2008. 118:65–71.

42. Crisci E, Barcena J, Montoya M. Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol. 2012. 06. 01. [Epub]. http://dx.doi.org/10.1016/j.vetimm.2012.04.026.

43. Liu F, Ge S, Li L, Wu X, Liu Z, Wang Z. Virus-like particles: potential veterinary vaccine immunogens. Res Vet Sci. 2012. 93:553–559.

44. Oem JK, Park JH, Lee KN, et al. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine. 2007. 25:4112–4121.

45. Ko YJ, Choi KS, Nah JJ, et al. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2005. 12:922–929.

46. Jeoung HY, Lee WH, Jeong W, Ko YJ, Choi CU, An DJ. Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus. Res Vet Sci. 2010. 89:295–300.

47. Jeoung HY, Shin BH, Jeong W, Lee MH, Lee WH, An DJ. A novel vaccine combined with an alum adjuvant for porcine encephalomyocarditis virus (EMCV)-induced reproductive failure in pregnant sows. Res Vet Sci. 2012. 03. 23. [Epub]. http://dx.doi.org/10.1016/j.rvsc.2012.02.012.

48. Medina E, Guzman CA. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine. 2001. 19:1573–1580.

49. Park SI, Jeong JH, Choy HE, et al. Immune response induced by ppGpp-defective Salmonella enterica serovar Gallinarum in chickens. J Microbiol. 2010. 48:674–681.

50. Nandre RM, Chaudhari AA, Matsuda K, Lee JH. Immunogenicity of a Salmonella Enteritidis mutant as vaccine candidate and its protective efficacy against salmonellosis in chickens. Vet Immunol Immunopathol. 2011. 144:299–311.

51. Matsuda K, Chaudhari AA, Lee JH. Evaluation of safety and protection efficacy on cpxR and lon deleted mutant of Salmonella Gallinarum as a live vaccine candidate for fowl typhoid. Vaccine. 2011. 29:668–674.

52. Hur J, Song SO, Lim JS, Chung IK, Lee JH. Efficacy of a novel virulence gene-deleted Salmonella Typhimurium vaccine for protection against Salmonella infections in growing piglets. Vet Immunol Immunopathol. 2011. 139:250–256.

53. Hur J, Lee JH. Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis. Vet Microbiol. 2010. 143:270–276.

54. Lee JS, Shin KS, Pan JG, Kim CJ. Surface-displayed viral antigens on Salmonella carrier vaccine. Nat Biotechnol. 2000. 18:645–648.

55. Choi J, Shin D, Ryu S. Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice. Vaccine. 2010. 28:6436–6444.

56. Lee J, Kim YB, Kwon M. Outer membrane protein H for protective immunity against Pasteurella multocida. J Microbiol. 2007. 45:179–184.

57. Lee J, Woo HJ. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin. J Microbiol Biotechnol. 2010. 20:1756–1763.

58. Kim TG, Kim BG, Kim MY, Choi JK, Jung ES, Yang MS. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus. Mol Biotechnol. 2010. 44:14–21.

59. Wilson RL, Hruby DE. Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism. Adv Drug Deliv Rev. 2005. 57:1392–1402.

60. Hur J, Lee JH. Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model. J Vet Med Sci. 2011. 73:1265–1273.

61. Chu H, Kang S, Ha S, et al. Lactobacillus acidophilus expressing recombinant K99 adhesive fimbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coli. Microbiol Immunol. 2005. 49:941–948.

62. Kim SB, Kim SJ, Lee BM, et al. Oral administration of Salmonella enterica serovar Typhimurium expressing swine interleukin-18 induces Th1-biased protective immunity against inactivated vaccine of pseudorabies virus. Vet Microbiol. 2012. 155:172–182.

63. Han YW, Kim SB, Rahman M, et al. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus. Comp Immunol Microbiol Infect Dis. 2011. 34:335–345.

64. An SJ, Yoon YK, Kothari S, et al. Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine. Vaccine. 2012. 30:1023–1028.

65. Cho NH, Seong SY, Chun KH, et al. Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. J Control Release. 1998. 53:215–224.

66. Seong SY, Cho NH, Kwon IC, Jeong SY. Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae. Infect Immun. 1999. 67:3587–3592.

67. Callaway TR, Anderson RC, Edrington TS, et al. Recent pre-harvest supplementation strategies to reduce carriage and shedding of zoonotic enteric bacterial pathogens in food animals. Anim Health Res Rev. 2004. 5:35–47.

68. Adam K, Brulisauer F. The application of food safety interventions in primary production of beef and lamb: a review. Int J Food Microbiol. 2010. 141:Suppl 1. S43–S52.